150 related articles for article (PubMed ID: 20173677)
1. Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy urban adolescents in the United States.
Cunningham CK; Rudy BJ; Xu J; Bethel J; Kapogiannis BG; Ahmad S; Wilson CM; Flynn PM;
Pediatr Infect Dis J; 2010 Jun; 29(6):530-4. PubMed ID: 20173677
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
[TBL] [Abstract][Full Text] [Related]
3. Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study.
Burgess MA; Rodger AJ; Waite SA; Collard F
Vaccine; 2001 Sep; 19(32):4835-41. PubMed ID: 11535336
[TBL] [Abstract][Full Text] [Related]
4. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811
[TBL] [Abstract][Full Text] [Related]
6. Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccines.
Nothdurft HD; Dietrich M; Zuckerman JN; Knobloch J; Kern P; Sänger R
BioDrugs; 2003; 17 Suppl 1():15-8. PubMed ID: 12785873
[No Abstract] [Full Text] [Related]
7. Two-dose combined vaccination against hepatitis A and B in healthy subjects aged 11-18 years.
Van Herck K; Van Damme P; Collard F; Thoelen S
Scand J Gastroenterol; 1999 Dec; 34(12):1236-40. PubMed ID: 10636072
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimens.
Flynn PM; Cunningham CK; Rudy B; Wilson CM; Kapogiannis B; Worrell C; Bethel J; Monte D; Bojan K;
J Acquir Immune Defic Syndr; 2011 Apr; 56(4):325-32. PubMed ID: 21350366
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
[TBL] [Abstract][Full Text] [Related]
11. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
Van Damme P; Van Herck K
Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
[TBL] [Abstract][Full Text] [Related]
12. A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years.
Van Der Wielen M; Van Damme P; Collard F
Pediatr Infect Dis J; 2000 Sep; 19(9):848-53. PubMed ID: 11001108
[TBL] [Abstract][Full Text] [Related]
13. A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine.
Li F; Hu Y; Zhou Y; Chen L; Xia W; Song Y; Tan Z; Gao L; Yang Z; Zeng G; Han X; Li J; Li J
Pediatr Infect Dis J; 2017 May; 36(5):e157-e161. PubMed ID: 28060048
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
[TBL] [Abstract][Full Text] [Related]
15. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
[TBL] [Abstract][Full Text] [Related]
16. [Results of Russian multicenter trial of immunogenicity, reactogenicity and safety of new combination vaccine against hepatitis A and B (Twinrix)].
Tatochenko VK; Il'ina NI; Romanenko VV; Alikova OA; Fassakhov RS; Miasnikova TN; Patlusova VV; Zima IuIu; Reshetnikova ID; Frolova GS; Smolenov IV
Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):30-5. PubMed ID: 17163135
[TBL] [Abstract][Full Text] [Related]
17. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
Tung J; Carlisle E; Smieja M; Kim PT; Lee CH
Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640
[TBL] [Abstract][Full Text] [Related]
18. Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.
Beran J
Expert Rev Vaccines; 2007 Dec; 6(6):891-902. PubMed ID: 18377352
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults.
Joines RW; Blatter M; Abraham B; Xie F; De Clercq N; Baine Y; Reisinger KS; Kuhnen A; Parenti DL
Vaccine; 2001 Sep; 19(32):4710-9. PubMed ID: 11535321
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in healthy Chilean subjects.
Prado V; Riedemann S; Ibarra H; Potin M
Int J Infect Dis; 2002 Jun; 6(2):129-33. PubMed ID: 12121601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]